FRIDAY, June 26 (HealthDay News) -- Cases of invasive breast cancer in the United States have declined overall, but the decrease is significantly less marked in poor women who live in rural areas, possibly due to differences in the use of hormone therapy (HT), a new study suggests.
Researchers at the Northern California Cancer Center studied national breast cancer incidence data for the years 1997 to 2004 to compare rates in rural and urban areas and poor and rich areas of the country.
"Between 2001 and 2004, incidence rates of invasive breast cancer declined more than 8 percent in the United States," study leader Christina Clarke said in a news release. "One possible explanation for this is widespread discontinuation of and/or failure to initiate HT. Because this cessation of HT use was more pronounced in rich/urban areas, we wanted to see if there was a corresponding difference in breast cancer incidence between these areas and poor/rural parts of the country."
She and her colleagues found that overall invasive breast cancer incidence declined 13.2 percent, with notable differences between urban (-13.8 percent) and rural (-7.5 percent) women, and those in counties with high (-9.6 percent), middle (-13.8 percent) and low (-13 percent) poverty rates.
The researchers noted that breast cancer incidence rates in rural counties peaked in 1999 and then declined steadily, while rates in urban counties fell dramatically after 2002. This difference may be because of variations in levels of exposure to news linking hormone therapy with breast cancer. The fact that women in urban areas had more exposure to media reports about the HT/breast cancer relationship likely contributed to a larger decrease in hormone therapy among those women.
"Understanding what specific populations were involved in breast cancer declines helps us to better plan prevention efforts for the future, especially with the aging of the baby boomer population into prime breast cancer age," Clarke said.
The study appears in the journal BMC Medicine.
More information
The U.S. National Cancer Institute has more about hormone therapy and cancer.
SOURCE: BioMed Central, news release, June 25, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Today's Top News Stories |
• | Cetuximab Helps Treat Colorectal Cancer - Nov 25, 2009, 12:00
Drug plus chemo boosts surgery success for patients with liver lesions, researchers find. |
• | Salt Really Does Boost Health Risks - Nov 25, 2009, 09:00
Links to stroke, cardiovascular disease may make a case for population-wide reduction, review finds. |
• | Natural Soy Component May Help Treat Colon Cancer - Nov 25, 2009, 12:00
Discovery in fruit fly study may lead to new drugs for people, researchers say. |
• | Holiday Eating Without the Guilt -- or the Pounds - Nov 25, 2009, 12:00
Two experts offer waistline-friendly ways to enjoy festive feasting. |
• | ER Visits for Elderly Rise During Thanksgiving - Nov 25, 2009, 09:00
Experts say family members can panic, underestimate effects of normal aging. |
